3.96
price down icon4.58%   -0.19
pre-market  시장 영업 전:  4.07   0.11   +2.78%
loading
전일 마감가:
$4.15
열려 있는:
$4.17
하루 거래량:
533.20K
Relative Volume:
0.74
시가총액:
$131.46M
수익:
-
순이익/손실:
$-86.60M
주가수익비율:
-1.3981
EPS:
-2.8324
순현금흐름:
$-67.37M
1주 성능:
-10.81%
1개월 성능:
+1.28%
6개월 성능:
-18.85%
1년 성능:
-64.61%
1일 변동 폭
Value
$3.86
$4.2664
1주일 범위
Value
$3.86
$4.50
52주 변동 폭
Value
$1.45
$13.63

Lexeo Therapeutics Inc Stock (LXEO) Company Profile

Name
명칭
Lexeo Therapeutics Inc
Name
전화
(212) 547-9879
Name
주소
345 PARK AVENUE SOUTH, NEW YORK
Name
직원
75
Name
트위터
Name
다음 수익 날짜
2025-03-24
Name
최신 SEC 제출 서류
Name
LXEO's Discussions on Twitter

LXEO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
LXEO
Lexeo Therapeutics Inc
3.96 239.68M 0 -86.60M -67.37M -2.8324
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-06-13 개시 Robert W. Baird Outperform
2024-06-06 개시 H.C. Wainwright Buy
2023-11-28 개시 Chardan Capital Markets Buy
2023-11-28 개시 JP Morgan Overweight
2023-11-28 개시 Leerink Partners Outperform
2023-11-28 개시 RBC Capital Mkts Outperform
2023-11-28 개시 Stifel Buy
모두보기

Lexeo Therapeutics Inc 주식(LXEO)의 최신 뉴스

pulisher
Jul 20, 2025

Is Lexeo Therapeutics Inc. a good long term investmentUnstoppable profit momentum - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

Lexeo Therapeutics Inc. Stock Analysis and ForecastExceptional return forecasts - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Lexeo Therapeutics Inc. stockFree Stock Index Interpretation - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Lexeo Therapeutics Inc. stock priceUnprecedented growth rates - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Will Lexeo Therapeutics Inc. stock split in the near futureSafe and Smart Investment Picks - beatles.ru

Jul 19, 2025
pulisher
Jul 18, 2025

Lexeo Therapeutics (NASDAQ:LXEO) & Organogenesis (NASDAQ:ORGO) Head to Head Analysis - Defense World

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Lexeo Therapeutics Inc. stock outlookFree Investment Portfolio Suggestions - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

How high can Lexeo Therapeutics Inc. stock price go in 2025Safe and Smart Investment Picks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

What makes Lexeo Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - beatles.ru

Jul 17, 2025
pulisher
Jul 15, 2025

Why Lexeo Therapeutics Inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Lexeo Therapeutics Inc. stock performs during market volatilityCarefully Curated High Return Stocks - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Lexeo Therapeutics soars 96% following March Fair Value signal By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Lexeo Therapeutics soars 96% following March Fair Value signal - Investing.com

Jul 11, 2025
pulisher
Jul 07, 2025

Stifel reiterates Buy rating on Lexeo Therapeutics stock at $21 price target - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Stifel reiterates Buy rating on Lexeo Therapeutics stock at $21 price target By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics stock rises after FDA breakthrough designation By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics Secures FDA Breakthrough Therapy Designation for LX2006, Shares Rise 8% in Pre-market Trade. - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics announces FDA Breakthrough Therapy Designation for LX2006 - TipRanks

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia Treatment - Nasdaq

Jul 07, 2025
pulisher
Jul 07, 2025

FDA grants breakthrough therapy designation to Lexeo’s FA treatment - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

FDA Breakthrough: Lexeo's Gene Therapy Shows Promise in Fatal Rare Disease Treatment - Stock Titan

Jul 07, 2025
pulisher
Jul 07, 2025

FDA grants breakthrough therapy designation to Lexeo’s FA treatment By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 01, 2025

LXEO files 41.6M-share prospectus; $80M raise backs accelerated LX2006 plan | ATNFW SEC FilingForm 8-K - Stock Titan

Jul 01, 2025
pulisher
Jul 01, 2025

LXEO files 41.6M-share prospectus; $80M raise backs accelerated LX2006 plan - Stock Titan

Jul 01, 2025
pulisher
Jun 30, 2025

Lexeo Therapeutics stockholders elect directors and ratify auditor at annual meeting - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Lexeo Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 30, 2025
pulisher
Jun 29, 2025

Lexeo Therapeutics, Inc.(NasdaqGM: LXEO) dropped from Russell 2000 Growth Index - MarketScreener

Jun 29, 2025
pulisher
Jun 27, 2025

Lexeo Therapeutics, PXV Funds and venBio launch new entity to advance RNA therapies for cardiac diseases - Pharmafile

Jun 27, 2025
pulisher
Jun 24, 2025

Lexeo Therapeutics Partners with PXV Funds, venBio on New Cardiac RNA Therapeutics Venture - MarketScreener

Jun 24, 2025
pulisher
Jun 16, 2025

Bank of America Corp DE Trims Stock Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Lexeo Therapeutics files to sell 41.63M shares of common stock for holders - MSN

Jun 14, 2025
pulisher
Jun 14, 2025

Lexeo Therapeutics (LXEO) Proposes Sale of 41.63 Million Shares - GuruFocus

Jun 14, 2025
pulisher
Jun 13, 2025

Lexeo Therapeutics Registers Share Offering on Behalf of Selling Stockholders - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Lexeo Therapeutics (LXEO) Proposes Sale of 41.63 Million Shares | LXEO Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Reduces Stock Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Stake Lifted by Wellington Management Group LLP - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Shares Acquired by Millennium Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Buys 8,378 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Wilson Sonsini Advises Lexeo Therapeutics on $80 Million Private Placement Equity Financing - Wilson Sonsini

Jun 02, 2025

Lexeo Therapeutics Inc (LXEO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):